Equities

Medical Data Vision Co Ltd

3902:TYO

Medical Data Vision Co Ltd

Actions
Health CareHealth Care Providers
  • Price (JPY)415.00
  • Today's Change2.00 / 0.48%
  • Shares traded397.60k
  • 1 Year change-39.68%
  • Beta1.4108
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform0
Hold2
Sell0
Strong Sell0

Share price forecast in JPY

The 2 analysts offering 12 month price targets for Medical Data Vision Co Ltd have a median target of 480.00, with a high estimate of 520.00 and a low estimate of 440.00. The median estimate represents a 15.66% increase from the last price of 415.00.
High25.3%520.00
Med15.7%480.00
Low6.0%440.00

Dividends in JPY

In 2023, Medical Data Vision Co Ltd reported a dividend of 6.50 JPY, which represents a 8.33% increase over last year. The 2 analysts covering the company expect dividends of 6.50 JPY for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)8.33%
More ▼

Earnings history & estimates in JPY

On Nov 11, 2024, Medical Data Vision Co Ltd reported 3rd quarter 2024 losses of -5.98 per share.
Average growth rate-176.39%
Medical Data Vision Co Ltd reported annual 2023 earnings of 25.63 per share on Feb 13, 2024.
Average growth rate+19.78%
More ▼

Revenue history & estimates in JPY

Medical Data Vision Co., Ltd. had 3rd quarter 2024 revenues of 1.35m. This missed the 1.88m consensus estimate of the 2 analysts following the company. This was 13.73% below the prior year's 3rd quarter results.
Average growth rate-0.29%
Medical Data Vision Co., Ltd. had revenues for the full year 2023 of 6.42m. This was 5.16% above the prior year's results.
Average growth rate+12.60%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.